Background: We documented the dependence of ethanol (EtOH)-evoked myocardial dysfunction on estrogen (E 2 ), and our recent estrogen receptor (ER) blockade study, in proestrus rats, implicated ERa signaling in this phenomenon. However, a limitation of selective pharmacological loss-of-function approach is the potential contribution of the other 2 ERs to the observed effects because crosstalk exists between the 3 ERs. Here, we adopted a "regain"-of-function approach (using selective ER subtype agonists) to identify the ER subtype(s) required for unraveling the E 2 -dependent myocardial oxidative stress/dysfunction caused by EtOH in conscious ovariectomized (OVX) rats.
W E DOCUMENTED THE estrogen (E 2 ) dependence of ethanol (EtOH)-evoked myocardial dysfunction and hypotension because these effects are absent in ovariectomized (OVX) and male rats, and manifest in both preparations following E 2 administration Abdel-Rahman, 2014, 2015) . These findings, which are reminiscent of E 2 -dependent cardiovascular deficits following chronic EtOH administration (El-Mas and Abdel-Rahman, 2000) , might be clinically relevant because EtOH reduces blood pressure (BP) in young, but not in older, women or men (Bae et al., 2012; Klatsky et al., 1990) . Our recent study identified a pivotal role for the estrogen receptor (ER) subtype ERa in the E 2 -dependent myocardial dysfunction caused by EtOH (Yao and Abdel-Rahman, 2016) . However, the use of selective ER blockade in proestrus rats (highest level of endogenous E 2 ) in the latter study or the use of genetic ER-knockout models (Sharma and Prossnitz, 2016) might confound data interpretation because a functional crosstalk exists between the 3 ERs (Shi et al., 2013) . This limitation could be circumvented by adopting a "regain"-offunction approach to identify the ER subtype(s) required for restoring EtOH-evoked myocardial oxidative stress/dysfunction in conscious OVX rats. Such studies have become feasible following the availability of highly selective ERa (PPT), ERb (DPN), and G protein-coupled ER (GPER, G1) agonists (Mata et al., 2015) .
The elucidation of the ER subtype(s) implicated in a paradoxical transformation of E 2 into a pro-inflammatory hormone in the presence of conditions that promote cellular oxidative stress (White et al., 2010) is important for understanding the molecular mechanisms of the sex (E 2 )-dependent adverse hemodynamic effects of alcohol in females. All 3 ER subtypes, ERa, ERb, and GPER, are distributed throughout the cardiovascular system (Meyer et al., 2006 (Meyer et al., , 2011 and confer favorable redox and functional cardiac effects under physiopathological conditions via both genomic and rapid signaling mechanisms (Lee et al., 2014; Weil et al., 2010) . In OVX rats, acute E 2 administration enhances the activity of 2 cardiac enzymes, catalase and mitochondrial aldehyde dehydrogenase 2 (mitALDH2) (ElMas and Abdel-Rahman, 2014) , which serve antioxidant roles (Kandadi et al., 2012; Ma et al., 2010; Ren et al., 2007) . Notably, these 2 enzymes also catalyze EtOH oxidative metabolism (Kinoshita et al., 2001; Soffia and Penna, 1987) and determine the level of the pro-oxidant metabolite acetaldehyde (Comporti et al., 2010) . Therefore, identifying the ERs that activate these 2 enzymes is critical for our understanding of paradoxical myocardial oxidative stress caused by combining E 2 and EtOH.
EtOH-evoked accumulation of cardiotoxic molecules such as malondialdehyde (MDA) and reactive oxygen species (ROS) (El-Mas and Abdel-Rahman, 2014 ) is exacerbated in the presence of E 2 (El-Mas and Abdel-Rahman, 2014; Ibrahim et al., 2014) . Further, E 2 is required for mediating the protein kinase B (Akt)/nitric oxide synthase (NOS)-dependent myocardial dysfunction caused by EtOH in female rats (El-Mas et al., 2009 . Collectively, these cellular effects are expected to compromise the antioxidant/detoxifying effects of mitALDH2 (Kandadi et al., 2012; Ma et al., 2010; Ren et al., 2007) , and ultimately result in EtOH-evoked myocardial oxidative stress/dysfunction.
The main aim of this study was to identify the ER subtype(s) implicated in the E 2 -dependent adverse biochemical and cardiac effects of EtOH. To achieve this goal, we conducted targeted ERa, ERb, or GPER restoration of function studies, using the respective highly selective agonist (PPT, DPN, or G1), in the absence or presence of EtOH in conscious OVX rats. Notably, in OVX rats, the activation of 1 or more ER subtype function, by the endogenous nonselective ER agonist E 2 , is required for the manifestation of EtOH-evoked myocardial oxidative stress and dysfunction (El-Mas and Abdel-Rahman, 2014) . This experimental approach also generated important data on the role of the individual ER subtype(s) in the E 2 -dependent activation of 2 myocardial enzymes, catalase and mitALDH2, which exert favorable redox function and, along with alcohol dehydrogenase (ADH) and cytochrome P450 2E1 (CYP2E1), catalyze oxidative metabolism of EtOH.
MATERIALS AND METHODS

Animals
Sprague-Dawley rats (female, 175 to 200 g) were purchased from Charles River (Raleigh, NC) and kept in the university animal care center keeping the temperature at 23 AE 1°C, humidity at 50 AE 10%, and a 12-hour light/dark cycle. Rats were housed in pairs in plastic boxes and allowed food (Prolab Rodent Chow; Granville Milling, Creedmoor, NC) and water freely for at least 1 week. Two weeks after ovariectomy (OVX), vascular and left ventricular catheterizations were conducted 1 day before the hemodynamic studies. All surgical procedures were conducted under sterile conditions. The animal was anesthetized (i.p.) by a mixture of ketamine (90 mg/kg) and xylazine (10 mg/kg). Buprenorphine (0.03 mg/kg; s.c) was used for pre-and postoperative analgesia, and Durapen (10,000 units/kg; St Joseph, MO) to guard against infection. Only 1 rat was kept in a cage after surgery. All the surgical procedure, postoperative care, and experimental protocols were approved by the East Carolina University Institutional Animal Care and Use Committee and were consistent with the Guide for the Care and Use of Laboratory Animals (2011).
Ovariectomy
Ovariectomy, detailed in our previous studies (El-Mas and Abdel-Rahman, 2000) , was conducted via a longitudinal skin incision (about 2 cm) on the lower part of the back after separating the muscles overlying the ovaries on both sides. The ovaries were isolated, tied off with sterile suture, and removed. The muscles were closed by sterile suture (Roboz Surgical Instrument Co., Gaithersburg, MD), and the skin was closed by suture wound clips (Mikron Precision Inc., Gardena, CA). Povidone-iodine solution was used for disinfection. The rats were kept for 2 weeks after ovariectomy to ensure depletion of endogenous E 2 in accordance with an established protocol in our laboratory (El-Mas and Abdel-Rahman, 2000) .
Vascular and left ventricular catheterizations were performed as detailed in our recent study (Yao and Abdel-Rahman, 2016) . Briefly, gas-sterilized arterial and venous catheters (Konigsberg Instruments Inc., Pasadena, CA), filled with heparinized saline, were placed into the abdominal aorta and vena cava via the femoral artery/vein for monitoring BP and for the administration of EtOH and/or the pharmacological intervention, respectively. A PE50 tubing was placed into left ventricle via the right carotid artery for the measurement of left ventricular function. All catheters were subcutaneously tunneled to the back of the neck, existed between the scapulae, plugged with sterile stainless steel pins, and attached to the skin with 3M VetbondTM tissue adhesive (Animal Care Products, St. Paul, MN).
Hemodynamic Recording
Left ventricular function and BP measurements were conducted in conscious freely moving rats as detailed in our previous studies (Ibrahim et al., 2014; Yao and Abdel-Rahman, 2016) . The arterial and left ventricular catheters were connected to Gould-Statham (Oxnard, CA) pressure transducers and flushed with heparinized saline (100 IU/ml). The animal was allowed to adapt to the environment for at least 30 minutes. BP and left ventricular indices were simultaneously recorded by ML870 (PowerLab 8/30; Colorado Springs, CO) and analyzed by LabChart (v.7) pro software (AD Instruments, Colorado Spring, CO).
Determination of Plasma EtOH Concentration
Measurement of EtOH concentration is detailed in our previous studies (Yao and Abdel-Rahman, 2016) . Briefly, sample and standard reactions were conducted in 96-well plate. The absorbance was detected at 340 nm by Infinite Ò 200 PRO multimode microplate readers (Tecan Group Ltd., M€ annedorf, Switzerland). The EtOH concentration was determined based on concurrently constructed EtOH standard calibration curve.
Measurement of Myocardial Catalase and mitALDH2 Activity
Left ventricular tissue was homogenized in PBS on ice and centrifuged at 4°C, at 8,1609g for 10 minutes. The supernatant was collected for measurements. As described in the manufacturer's protocol and in our studies Ibrahim et al., 2014; Yao and Abdel-Rahman, 2016) , 5 lg of sample protein was used to measure the catalytic activity by colorimetric catalase assay kit (Sigma-Aldrich, St. Louis, MO). The absorbance was read at 520 nm. A mit ALDH2 activity assay kit (Abcam, Ann Arbor, MI) was used for the measurement of mitALDH2 activity in 500 lg sample protein and the absorbance was read at 450 nm every 3 minutes for 1 hour.
Measurement of ADH
We followed the protocol for enzymatic assay of ADH (EC 1.1.1.1) (Sigma-Aldrich) to measure ADH activity. Heart tissue was homogenized in PBS (pH 7.5) and centrifuged at 8,1609g for 10 minutes. Baseline absorbance was read at 340 nm after adding 90 ll of sodium pyrophosphate buffer (50 mM, PH 8.8), 100 ll of b-nicotinamide adenine dinucleotide (b-NAD, 15 mM, freshly prepared), and 10 ll of 95% EtOH in each well of a 96-well plate. Next, we added 20 ll of the supernatant of each sample homogenate, and 20 ll of escalated concentrations of freshly prepared ADH (0 to 1.2 units/ml), in adjacent 6 wells, to obtain a standard curve. Absorbance was measured again at 340 nm, and the difference between baseline and final absorbance was used to calculate the ADH activity from the standard curve.
Measurement of CYP2E1 Activity
CYP2E1 activity was measured in heart tissue homogenate by the method of oxidation of p-nitrophenol (PNP, 4-nitrophenol) to p-nitrocatechol by CYP2E1 in the presence of NADPH as reported (Zhang et al., 2011) with modification. Briefly, 200 ll reaction medium containing 500 lg protein, 100 mM potassium phosphate buffer (pH 7.4), 2 mM PNP, and 1 mM NADPH was incubated at 37°C for 60 minutes, then terminated by 30 ll of 20% trichloroacetic acid. After centrifugation (8,1609g for 10 minutes), 200 ll of the supernatant was mixed with 10 ll of 10 M NaOH in a 96-well plate, and the optical density was read at 546 nm.
Measurement of Myocardial Nitrite/Nitrate (NOx) Level
Left ventricular tissue was homogenized in PBS on ice and centrifuged at 2,0409g for 10 minutes, at 4°C. The supernatant was collected and ultrafiltered by a 10-kDa molecular weight filter for the measurement of NOx using nitrite/nitrate colorimetric assay kit (Cayman Chemical Company, Ann Arbor, MI) as described in our previous studies Yao and Abdel-Rahman, 2016) . The filtrate (80 ll containing 30 lg of protein) was used for a reaction with nitrate reductase mixture and enzyme cofactor mixture. The O.D value was read at 550 nm using Infinite Ò 200 PRO multimode microplate readers (Tecan Group Ltd.). NOx concentration was determined based on standard curve data.
Measurement of Myocardial ROS Level
Myocardial ROS levels were measured by a fluorometric assay using 2 0 ,7 0 -dichlorofluorescin diacetate (DCFH-DA; Molecular Probes-Thermo Fisher Scientific Inc, Raleigh, NC). Briefly, myocardial tissue was homogenized in PBS on ice and centrifuged at 2,0409g for 10 minutes. DCFH-DA (25 lM) was added to 250 lg of sample protein supernatant. The fluorescence intensities were measured in a 96-well plate every 5 minutes for 30 minutes with Infinite Ò 200 PRO multimode microplate readers (Tecan Group Ltd.) at 485 nm/530 nm for excitation/emission wavelengths at 37°C as in our previous reports (Yao and AbdelRahman, 2016 ).
Measurement of Myocardial MDA Level
TBARS assay kit (Cayman Chemical) was used to measure MDA level. Briefly, myocardial tissue was homogenized in RIPA buffer with protease inhibitors on ice and centrifuged at 8,1609g for 15 minutes. The supernatant (50 ll) was used to react with thiobarbituric acid (TBA) under high temperature (90 to 100°C) and acidic conditions. The MDA-TBA adduct was measured colorimetrically at 530 to 540 nm. A standard curve was used to calculate the MDA concentration.
Western Blot
We followed the protocols described in our studies (Ibrahim et al., 2014; Yao and Abdel-Rahman, 2016) . Left ventricular tissue was homogenized on ice in lysis buffer with protease inhibitor cocktail (Roche, Indianapolis, IN) and centrifuged (11,7509g for 15 minutes). Briefly, the supernatant protein (80 lg) was separated in a 4 to 12% gel electrophoresis (Novex Tris-Glycine gel; Life Technologies, Carlsbad, CA) and semidry-transferred to nitrocellulose membrane. The membranes were blocked in Odyssey blocking buffer (LI-COR Biosciences, Lincoln, NE) for 2 hours and incubated in primary antibody overnight at 4°C with shaking. The primary antibodies used were as follows: mouse anti-p-Akt (1:500) and rabbit anti-Akt (1:500; Cell Signaling, Danvers, MA); mouse anti-p-ERK1/2 (1:500) and rabbit anti-ERK1/2 antibodies (1:500; Cell Signaling); mouse anti-p-p38 (1:500) and rabbit anti-p38 (1:500; Cell Signaling); rabbit anti-pnNOS (Ser1417) (1:200) and mouse polyclonal anti-nNOS antibody (1:200; BD Biosciences, San Jose, CA); rabbit anti-p-eNOS (1:200; Thermo Fisher Scientific, Waltham, MA) and mouse polyclonal anti-eNOS antibody (1:200). Thereafter, the membranes were incubated with secondary antibody prepared by IRDye680-conjugated goat anti-mouse and IRDye800-conjugated goat anti-rabbit (1:15,000; LI-COR Biosciences) for 60 minutes after washing. Bands were detected by Odyssey Infrared Imager and quantified by integrated intensities with Odyssey application software version 3 (LI-COR Biosciences).
Experimental Groups and Protocols
The experimental design/schedule is presented in Fig. 1 . Experiment 1. Effect of Prior Selective ERa, ERb, or GPER Activation on Myocardial Function and BP in EtOH-treated OVX Female Rats. Based on our findings that acute E 2 administration unravels EtOH-evoked myocardial dysfunction in OVX rats (El-Mas and Abdel-Rahman, 2014), we investigated the roles of ERa, ERb, or GPER in this adverse effect of EtOH in 56 OVX rats, divided into 8 groups (6 to 8 rats/group). All rats were used in the conscious state, 2 weeks after ovariectomy, and 1 day after left ventricular and vascular catheterizations. At least 30 minutes was allowed for the hemodynamic variables to stabilize at baseline levels. Six groups were divided into 3 pairs and each pair received an i.v. (10 lg/kg) injection of an ERa (PPT), ERb (DPN), or GPER (G1) agonist 30 minutes before EtOH (1.0 g/kg; agonist + EtOH) or equal volume of saline (agonist + saline). The remaining 2 groups received vehicle (DMSO:saline, 1:50; control for ER agonists) 30 minutes before saline (control, vehicle + saline) or EtOH (vehicle + EtOH). The doses of the ER agonists were based on reported findings (Lu et al., 2009; Yang et al., 2007) , and the dose of EtOH was based on our previous study (Ibrahim et al., 2014) . Mean arterial pressure (MAP), left ventricular developed pressure (LVDP), and maximum rate of left ventricular pressure rise (dP/dt max ) were recorded for additional 60 minutes after a 30-minute infusion period of EtOH or saline, and analyzed by LabChart. At the conclusion of the hemodynamic measurements, the rats were euthanized, and tissues were collected, flash-frozen, and stored at À80°C for conducting the molecular studies as described below.
Experiment 2. Effect of Selective ER Subtype Activation on Modulators of Myocardial Redox State and EtOH-Metabolizing Enzymes. The catalytic activity of catalase and ALDH2, which serve antioxidant roles (Ma et al., 2010; Ren et al., 2007) , and catalyze EtOH metabolism (Kinoshita et al., 2001; Soffia and Penna, 1987) , is enhanced in the presence of E 2 (Campos et al., 2014) , but the ER subtype that mediates these effects in the absence or presence of EtOH is not known. Therefore, these ex vivo studies were conducted to elucidate the effect of selective activation of each of the 3 ER subtypes on myocardial alcohol-metabolizing enzymes (ADH, CYP2E1, and catalase), antioxidative enzymes (catalase and mitALDH2), and mediators of oxidative stress (MAKs) in the absence or presence of EtOH. Blood and left ventricular tissues were obtained from all rats employed in experiment 1 for the measurements of blood EtOH concentration and biochemical studies as detailed under Methods and in our recent studies (Ibrahim et al., 2014; Yao and Abdel-Rahman, 2016) .
Drugs
EtOH (Midwest Grain Products Co., Weston, MO) was diluted in saline. Propylpyrazole triol (PPT), 2, 3-bis (4-hydroxyphenyl) (DPN), and G1 were purchased from Cayman Chemical. The drugs were first dissolved in DMSO for stock solution. The working solution was the 1:50 diluted stock solution with saline.
Data Analysis and Statistics
Values are presented as mean AE SEM. The baseline data in Table 1 were analyzed by 1-way ANOVA. Differences in hemodynamic variables between before and after an ER subtype agonist administration (Table 1) were analyzed by paired t-test. Other data were analyzed by 1-way ANOVA followed by post hoc Tukey's t-test comparison. These statistical analyses were conducted by Prism version 5 (GraphPad Software, Inc. La Jolla, CA). p < 0.05 was considered significant.
RESULTS
Selective ERa or ERb Activation Unraveled EtOH-Evoked Myocardial Dysfunction and Hypotension in OVX Rats
The baseline hemodynamic variables measured in all conscious OVX rat groups were not statistically different (Table 1) . When administered alone, none of the selective ER subtype agonists (10 lg/kg; i.v.) influenced the measured hemodynamic variables (Table 1) . Similarly, EtOH (1.0 g/kg) administered alone had no effect on the measured variables (Figs 2 and 3) . Prior ERa (PPT) or ERb (DPN) activation unraveled (p < 0.05) EtOH-evoked reductions in dP/dt max ( Fig. 2A,A1) , LVDP (Fig. 2B,B1 ), and MAP (Fig. 3) . However, prior GPER activation (G1) only unraveled significant (p < 0.05), but modest (approx. 5 mmHg) hypotensive effect of EtOH, which was much smaller than that unraveled by ERa or ERb activation (Figs 2 and 3 ).
EtOH and PPT Produced Additive Enhancement of Myocardial Catalase Activity in OVX Rats
Here, we examined, for the first time, the effect of individual ER subtype activation in the absence or presence of EtOH on myocardial catalase, mitALDH2, ADH, and CYP2E1 activities in E 2 -depleted (OVX) rats. Notably, the 2 antioxidant enzymes, catalase and mitALDH2, are involved in EtOH oxidative metabolism, and their activities are suppressed in OVX hearts and restored following acute E 2 (nonselective ER agonist) administration in OVX rats Abdel-Rahman, 2014, 2015) . ERa (PPT) significantly (p < 0.05) enhanced both myocardial catalase and mitALDH2 activities, and alcohol (1.0 g/kg) caused further increase (p < 0.05) in catalase, but not mitALDH2 activity, in the presence of PPT (Fig. 4A,B) . While neither ERb nor GPER influenced myocardial catalase (Fig. 4A) , they significantly (p < 0.05) reduced mitALDH2 activity (Fig. 4B) , and these effects were not altered by alcohol (Fig. 4A,B) . None of the ER agonists influenced myocardial ADH (Fig. 5A) or CYP2E1 (Fig. 5B ) activity in the absence or presence of EtOH. Finally, blood EtOH level was significantly (p < 0.05, Fig. 4C ) lower in OVX rats pretreated with the ERa agonist PPT (59.8 AE 6.3 mg/dl) or ERb agonist DPN (62.9 AE 7.7 mg/dl), but not with the GPER agonist G1 (100.3 AE 10 mg/dl), compared with saline pretreatment (96.0 AE 8.6 mg/dl).
Alcohol Reversed the ERa-, ERb-, or GPER-Mediated Improvement of Myocardial Redox Status in OVX Rats
ERa (PPT), ERb (DPN), or GPER (G1) activation significantly (p < 0.05) suppressed myocardial ROS level (Fig. 6A ), but only PPT or DPN significantly (p < 0.05) suppressed MDA (Fig. 6B ) levels in OVX rats. Consequent Fig. 1 . A schematic timeline of the experimental design including surgery, hemodynamic recording, pharmacological interventions (ERa, ERb, or GPER agonist in the absence or presence of ethanol) in conscious ovariectomized rats and tissue collection for ex vivo biochemical/molecular studies.
EtOH administration reversed (p < 0.05) ROS suppression caused by PPT, DPN, or G1 (Fig. 6A) and MDA suppression caused by PPT or DPN (Fig. 6B ) in the myocardium of OVX rats that received the individual ER agonist plus alcohol. GPER activation (G1) had no effect on Akt, ERK1/2, and p38 phosphorylation in the absence or presence of EtOH (Fig. 7) . However, both PPT and DPN significantly (p < 0.05) increased Akt (Fig. 7A ), but only PPT decreased ERK1/2 (Fig. 7B ) phosphorylation, and these effects were reversed by EtOH (Fig. 7A,B ). While PPT alone had no effect, it uncovered significant (p < 0.05) increase in p38 phosphorylation when combined with EtOH (Fig. 7C) . On the other hand, DPN significantly (p < 0.05) and similarly increased p38 phosphorylation in the presence or absence of EtOH (Fig. 7C) . Finally, EtOH produced significant (p < 0.05) increases in eNOS phosphorylation when administered following PPT or DPN (Fig. 8A) , and significant (p < 0.05) increases in nNOS phosphorylation (Fig. 8B) and NOx (Fig. 8C) when administered following DPN. GPER activation (G1) alone or in combination with EtOH had no effect on these molecular responses (Fig. 8) .
DISCUSSION
In this study, we generated important data on the role of the individual ER subtype ERa, ERb, and GPER in the sex (E 2 )-dependent myocardial oxidative stress/dysfunction caused by alcohol. We show that a preexisting ERa or ERb activation is required for the manifestation of the adverse myocardial effects of EtOH in females. Our multidimensional approach helped us to elucidate the molecular mechanisms implicated in the counterintuitive transformation of the favorable E 2 -mediated myocardial redox status into deleterious cardiac effects in the presence of alcohol. These findings are relevant to women's cardiovascular health given the steady rise in alcohol use by women in the United States, and the potential use of selective ER subtype agonists, in lieu of E 2 , as hormone replacement therapy.
Our recent study presented indirect evidence for the contribution of all 3 ER subtypes to EtOH-evoked myocardial oxidative stress/dysfunction, but emphasized a role for ERa in initiating these adverse effects (Yao and Abdel-Rahman, 2016) . A limitation of the approach used in our previous study, which is shared with genetic ER subtype-knockout models (Sharma and Prossnitz, 2016) , is the concurrent signaling triggered by endogenous E 2 chronic activation of the other 2 ER subtypes when the targeted ER subtype is pharmacologically blocked or deleted. We resolved this limitation in the present study and generated physiologically relevant data by adopting the selective gain-of-function approach in E 2 -depleted (OVX) rat model because the loss of E 2 in OVX rats (i) inhibits EtOH-evoked myocardial dysfunction (ElMas and Abdel-Rahman, 2014) and (ii) suppresses the activities of myocardial catalase and mitALDH2 (El-Mas and Abdel-Rahman, 2015) , which confer favorable redox effects (Kandadi et al., 2012; Ma et al., 2010; Ren et al., 2007) and catalyze EtOH metabolism (Kinoshita et al., 2001; Soffia and Penna, 1987) . Importantly, these biochemical and EtOH-evoked hemodynamic responses are fully restored in OVX rats treated with chronic or acute E 2 (El-Mas and Abdel-Rahman, 1999 . Replacing the nonselective ER agonist E 2 with a highly selective ERa (PPT), ERb (DPN), or GPER (G1) agonist in OVX rats was adopted in the present study to determine the required ER subtype(s) for restoring EtOH-evoked adverse cardiac effects and hypotension in OVX rats.
Our pharmacological approach is supported by the ability of PPT, DPN, and G1, which exhibit several hundredfold selectivity to ERa, ERb, and GPER, respectively, to regain the targeted ER function (Bologa et al., 2006; Meyers et al., 2001; Stauffer et al., 2000) . Consistent with our previous studies Abdel-Rahman, 1999, 2014) , EtOH had no effect on cardiac function (Fig. 2) or BP (Fig. 3) in OVX rats. We show that regaining ERa or ERb function, following acute administration of its respective agonist, unraveled EtOH-evoked myocardial oxidative stress/dysfunction and hypotension in OVX rats (Figs 2, 3, and 6 ). These findings are reminiscent of the ability of acutely administered E 2 (nonselective ER agonist) to unravel the adverse cardiovascular effects of EtOH in OVX AbdelRahman, 1999, 2014) as well as in male (El-Mas and AbdelRahman, 2015) rats, and directly implicate ERa and ERb in the studied phenomenon. On the other hand, regaining GPER function only unraveled modest EtOH-evoked hypotension in OVX rats (Fig. 3) . Fig. 7 . The effect of selective ERa, ERb, or GPER activation by its respective agonist PPT, DPN, and G1 on myocardial Akt (A), ERK1/2 (B), and p38 (C) phosphorylation in the absence or presence of ethanol (1.0 g/kg) in ovariectomized (OVX) rats. Images under the bar graphs show representative Western blot bands of total and phosphorylated Akt, ERK1/ 2, and p38. Values are mean AE SEM. Data were analyzed by 1-way ANOVA followed by post hoc Tukey's t-test comparison. *p < 0.05, versus vehicle + saline; #p < 0.05, versus agonist + saline. Fig. 8 . The effect of selective ERa, ERb, or GPER activation by its respective agonist PPT, DPN, and G1 on myocardial endothelial nitric oxide synthase (eNOS; A) and neuronal nitric oxide synthase (nNOS; B) phosphorylation, as well as nitrite/nitrate level (NOx; C), in the absence or presence of ethanol (1.0 g/kg) in ovariectomized rats. Images under the bar graphs show representative Western blot bands of total and phosphorylated eNOS and nNOS. Values are mean AE SEM. Data were analyzed by 1-way ANOVA followed by post hoc Tukey's t-test comparison. *p < 0.05, versus vehicle + saline; #p < 0.05, versus agonist + saline.
It is important to consider the underlying biochemical environment following the regaining of each individual ER subtype function in OVX rats to understand the basis for their relative contribution to EtOH-evoked biochemical and hemodynamic effects. While reported studies including ours (Campos et al., 2014; Ibrahim et al., 2014; Yao and AbdelRahman, 2016) showed that E 2 enhances myocardial catalase and mitALDH2 activities in OVX rats, the present study is the first to show that these biochemical effects were only replicated following regaining ERa function (Fig. 4) . This is in marked contrast to an inhibitory role for ERb or GPER on mitALDH2 (Fig. 4B) . In addition to the physiological ramifications of these ER subtype-dependent alterations in the catalytic activity of these 2 myocardial antioxidant enzymes (White et al., 2010) , we must consider their impact on EtOH metabolism. This is important because catalase (Oshino et al., 1973) and mitALDH2 (Doser et al., 2009; Matsumoto et al., 1996) enhance EtOH oxidation to acetaldehyde and acetate, respectively. The ability of EtOH to further enhance catalase, but not mitALDH2 in OVX rats with regained ERa function (Fig. 4A,B) , is suggestive of acetaldehyde accumulation, which exerts greater cardiotoxic effects than EtOH (Sarc and Lipnik-Stangelj, 2009 ). On the other hand, acetaldehyde accumulation following ERb or GPER regaining of function might result, at least partly, from the lower mitALDH2 activity (Fig. 4B ) although this effect might be mitigated somewhat by EtOH-evoked increase in mitALDH2 in DPN-treated OVX rats (Fig. 4B) . Nonetheless, the contribution of ADH to EtOH metabolism in our model system must also be considered because E 2 suppresses hepatic ADH activity (Chrostek et al., 2003) .
Similar to our finding in the heart (Ibrahim et al., 2014) , EtOH (1.0 g/kg) enhanced ADH activity in the liver (Fig. S1A ) of sham-operated rats in an E 2 -dependent manner because EtOH had no effect on cardiac (Fig. 5A) or liver (Fig. S1A ) ADH activity in OVX rats. Further, the inability of EtOH to enhance cardiac (Fig. 5A) or liver (Fig. S2A ) ADH activity in OVX rats, pretreated with PPT, DPN, or G1, inferred that concomitant activation of 2 or all 3 ER subtypes is required for this action. We addressed this question in a validated in vitro model system in which EtOH (100 mg/dl; attained after 1.0 g/kg dose in vivo) enhanced ADH activity in isolated liver tissue from sham-operated rats (Fig. S3A) . Next, we showed that adding 2 or the 3 ER agonists to the incubation medium in reported concentrations (Shen and Shi, 2016) , compatible with those attained following their acute administration in the present study, did not reproduce the E 2 -dependent enhancement of hepatic ADH activity caused by alcohol in sham-operated rats in vivo (Fig. S1A ) or in vitro (Fig. S3A) . It is likely that concomitant chronic activation of 2 or the 3 ER subtypes is required to unravel EtOH (1.0 g/kg)-evoked enhancement of ADH activity in the heart (Ibrahim et al., 2014) and liver ( Fig. S1A ) of sham-operated rats. This conclusion gains credence from the findings that EtOH enhanced liver ADH activity in tissues isolated from sham-operated rats (Fig. S3A) , but not in tissues from OVX rats subjected to combined acute activation of the 3 ER subtypes (Fig. S3B) . Whether this phenomenon applies to E 2 -dependent effects of EtOH on other enzymes or kinases remains to be elucidated in future studies.
We also investigated the influence of activating the individual ER subtype on cardiac CYP2E1 activity, another enzyme that catalyzes alcohol oxidative metabolism, because its expression is increased by E 2 (Konstandi et al., 2013) . Consistent with the latter finding, hepatic CYP2E1 activity is significantly higher in sham-operated, compared with OVX, rats (Fig. S1B) . Further, acute (Haorah et al., 2005) or chronic (Takahashi et al., 1993) EtOH administration enhances CYP2E1 activity in different organs. Here, EtOH had no effect on cardiac CYP2E1 activity in the absence or the presence of PPT, DPN, or G1 (Fig. 5B) . It is likely that the reported effect of EtOH on CYP2E1 activity is organ dependent and influenced by the hormonal status. In support of this notion, EtOH enhanced CYP2E1 activity in the liver (Fig. S2B ), but not the heart (Fig. 5B ) of OVX rats, and had no effect on hepatic CYP2E1 activity in sham-operated rats (Fig. S1B ). More studies are needed to understand the mechanism of the dampening effect of the 3 ER subtypes on EtOH-evoked activation of hepatic CYP2E1 in the liver of OVX rats.
In our previous studies, acute nonselective activation of all ERs by E 2 had no effect on blood EtOH concentration in OVX (El-Mas and Abdel-Rahman, 2012) or male (El-Mas and Abdel-Rahman, 2015) rats. While averaging blood EtOH concentration in all OVX rats pretreated with the individual ER agonist agrees with our previous findings, the present study contributes new knowledge by demonstrating reduced blood EtOH level in PPT-or DPN-treated OVX rats. As discussed above, this reduction in blood EtOH concentration due, at least partly, to the alterations in catalase and mitALDH2 is indicative of higher levels of acetaldehyde or acetate, which are more cardiotoxic than EtOH (Sarc and Lipnik-Stangelj, 2009 ). These findings may also explain the higher acetaldehyde level, derived from similar amounts of alcohol, in women on birth control pills (Jeavons and Zeiner, 1984) .
The present study directly discerned the contribution of the individual ER subtype to the E 2 -dependent myocardial dysfunction caused by alcohol, which was a challenging task when we adopted the selective ER subtype blockade in our previous study (Yao and Abdel-Rahman, 2016) . While both studies suggest major contributions of ERa and ERb to EtOH-evoked myocardial dysfunction, here we show that ERa mediated the reduction in dP/dt max ( Fig. 2A,A1) and ERb mediated the reduction in LVDP (Fig. 2B,B1 ) caused by EtOH. These divergent responses might be explained, at least partly, by the differences in the autonomic and endocrine control of dP/dt max and LVDP (Gordan et al., 2015) . Notably, ERa and ERb play prominent roles in the heart and central nervous system, respectively (Arnal et al., 2012) , and play different roles in cardioprotection (Murphy, 2011) .
Our findings suggest a minimal role for GPER in these E 2 -dependent adverse hemodynamic effects of EtOH (Figs 2  and 3) . Nonetheless, these effects are expected to be additive to those mediated by ERa and ERb when the endogenous levels of E 2 are high in proestrus rats in our previous studies (Ibrahim et al., 2014) or in women receiving E 2 replacement therapy or birth control pills (Jeavons and Zeiner, 1984) .
Our findings showed that both PPT and DPN increased Akt and p38 phosphorylation (Fig. 7) , which agrees with favorable roles for these kinases in the salutary effects of E 2 on cardiac function (Favre et al., 2010; Hsu et al., 2007) . Further, the increases in ERK1/2 and p38 phosphorylation caused by PPT or DPN, but not by G1 (Fig. 7) , must be considered in the context of their roles in regulating cardiac function, particularly in the presence of EtOH. This is important because our earlier studies implicated enhanced AKt and ERK1/2 phosphorylation, and their mediation of NOS phosphorylation and ROS generation, in the E 2 -dependent myocardial dysfunction caused by similar doses of EtOH (El-Mas et al., 2009; Ibrahim et al., 2014; Yao and AbdelRahman, 2016) . Here, we extend these earlier findings by showing that ERa mediates ERK1/2 (Fig. 7B) , p38 (Fig. 7C) , and eNOS ( Fig. 8A ) phosphorylation, while ERb mediates ERK1/2 (Fig. 7B) , eNOS (Fig. 8A) , and nNOS ( Fig. 8B ) phosphorylation caused by EtOH in the female myocardium. GPER had no role in these molecular responses (Figs 7 and 8 ). These molecular findings might also explain the relatively greater reductions in dP/dt max ( Fig. 2A) and LVDP (Fig. 2B) (Fig. 7) .
It is imperative to discuss the roles of the ER subtypes in mediating the E 2 -dependent oxidative stress caused by EtOH because the OVX rat myocardium exhibits greater levels of 2 mediators of oxidative stress, ROS and MDA, and these elevations are reversed by E 2 to proestrus rat levels (Abbas and Elsamanoudy, 2011; El-Mas and Abdel-Rahman, 2014) . All ER subtypes mediated ROS reduction (Fig. 6A ), but only ERa or ERb mediated MDA reduction (Fig. 6B) in OVX rats, which is consistent with more favorable redox roles for ERa and ERb (Liu et al., 2009; Urata et al., 2006) . EtOH alone had no effect on the already elevated myocardial ROS and MDA in OVX rats (Fig. 6) , but reversed the ERa-or ERb-dependent reductions in ROS and MDA to OVX level (Fig. 6) . However, myocardial dysfunction occurred only when EtOH was combined with ERa or ERb agonist (Figs 2  and 3 ). These findings raise the interesting possibility that a preexisting higher oxidative stress in OVX (El-Mas and Abdel-Rahman, 2014) or male (El-Mas and Abdel-Rahman, 2015), compared to proestrus female rats, might protect the heart from the adverse effects of EtOH. In support of this premise, the resilience of the OVX or male rat heart to the adverse effect of EtOH is lost when myocardial oxidative stress was suppressed in both preparations by acute E 2 administration (El-Mas and Abdel-Rahman, 1999 . The present findings implicate ERa and ERb in this phenomenon.
The current study yields new insight into the role of ERa, ERb, or GPER in the E 2 -dependent myocardial dysfunction caused by alcohol via accumulation of cardiotoxic (ROS and MDA) and cardiodepressant (NOS-derived NO) molecules. Pharmacological and biochemical evidences support pivotal roles for ERa and ERb in this phenomenon although differences existed between their mediation of EtOH-evoked reductions in myocardial function indices. By contrast, GPER only contributed a modest role in EtOH-evoked hypotension. The findings highlight potential adverse hemodynamic interaction between selective ER agonists and EtOH in women with surgical menopause. If selective ER agonists are utilized as alternatives to E 2 replacement, the selective GPER agonist G1 represents a safer option for women with history of alcohol consumption.
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Appendix S1. Supplemental methods. Fig. S1 . ADH and CYP2E1 activities in livers isolated from sham-operated and OVX rats treated with EtOH (1 g/ kg) or saline in vivo. Fig. S2 . ADH and CYP2E1 activities in livers isolated from OVX rats treated with EtOH (1 g/kg) or saline in the absence or presence of PPT, DPN, or G1 (10 µg/kg). Fig. S3 . ADH activity measured in sham-operated rats' liver tissues incubated at 37 o C with EtOH or PBS (A) and in OVX rats' liver tissues pre-incubated, for 30 minutes, with vehicle, PPT, DPN, or G1 (1 µM), paired ER agonists or the 3 ER agonists before 90 minutes incubation with of EtOH (100 mg/dl) or PBS (B). Table S1 . The groups of rats from which livers were used in the in vitro Experiments (Fig. 3) to determine the effect of selective ER agonist (1 µM) alone or in combinations on liver ADH Activity in the presence or absence of ethanol (100 mg/dl).
